Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

ONN® - OncLive News Network®

May 15, 2019

May 23rd 2019

A Role for Immune-Oncology + Locoregional Therapy in HCC

May 13th 2019

May 8, 2019

May 11th 2019

May 1, 2019

May 6th 2019

KEYNOTE-146: A New Treatment Option for Advanced Endometrial Cancer

April 30th 2019

April 24, 2019

April 30th 2019

Impassion130: The First Approval of I-O Therapy in TNBC

April 29th 2019

April 17, 2019

April 19th 2019

April 10, 2019

April 16th 2019

April 3, 2019

April 8th 2019

March 28, 2019

April 1st 2019

A Practical Approach to the Treatment of Metastatic CRC

March 29th 2019

March 20, 2019

March 24th 2019

Novel Approaches to Treatment of Hepatocellular Carcinoma

March 22nd 2019

March 13, 2019

March 18th 2019

March 6, 2019

March 9th 2019

February 27, 2019

March 1st 2019

February 20, 2019

February 24th 2019

February 13, 2019

February 16th 2019

Post-Conference Perspectives: Sequencing in the Current mCRC Paradigm

February 8th 2019

February 6, 2019

February 7th 2019

January 30, 2019

February 3rd 2019

ASCO GI 2019: Post-Conference News on CRC

January 31st 2019

Post-Conference Perspectives: Peripheral T-Cell Lymphoma

January 28th 2019

January 23, 2019

January 25th 2019

January 16, 2019

January 19th 2019

January 9, 2019

January 14th 2019

Post-Conference Perspectives: Breast Cancer Recurrence Score

January 2nd 2019

Post-Conference Perspectives: Update on PARP Inhibitors in Breast Cancer

December 28th 2018

December 19, 2018

December 27th 2018
  • Prev
  • 1
  • More pages
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • More pages
  • 20
  • Next
  • Prev
  • Next

Advertisement
Advertisement

Trending on OncLive

1

FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer

2

Bispecific-Based Approaches Highlight Key Multiple Myeloma Data Set to Emerge at EHA 2026

3

Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026

4

CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026

5

First-Line Zanubrutinib Is Associated With Improved Real-World Efficacy in Older Patients With CLL

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us